Brought to you by www.DealSearchOnline.com
 

February 25, 2013 Issue:
 

Recent Health Care M&A Deals 

Where Did All the Deals Go?–
M&A Activity Goes Off the Fiscal Cliff in January

Spotlight on: Pharmaceuticals

Webcast Calendar

Recent Health Care M&A Deals

BIOTECHNOLOGY

Acquirer

Target

Price

Roche Holding AG

Rights to Octreolin

$65 million

E-HEALTH

Acquirer

Target

Price

PipelineRx

Evolute Consolidated Holdings

N/A

LABORATORIES, MRI AND DIALYSIS

Acquirer

Target

Price

DSI Renal

New Smyrna Beach Artificial Kidney Center

N/A

M&A Strategies to Navigate the Changing Landscape in Health Care      
The 2nd Annual Leadership Summit on Mergers and Acquisitions in Health Care taking place April 8-10, 2013 in Washington, D.C. provides a unique opportunity to hear from leading industry experts discussing the latest M&A activities and the trends and market opportunities that health care organizations must take full advantage of if they want to maintain market share and increase revenues. Attendees will have the opportunity to interact with health plans and provider groups to hear first hand the challenges they encountered on deals they negotiated and the lessons learned from their experiences. Additionally, attendees will be able to learn from leading private equity firms and investors what sectors within healthcare they are focusing on and why. For more information or to register visit www.worldcongress.com/mergers.
 
Where Did All the Deals Go?
M&A Activity Goes Off the Fiscal Cliff in January
The equity markets are staging their own version of a mid-winter comeback, with the Dow dancing around the 14,000 mark for the first time in five years. That would certainly seem to presage a similar rise in health care mergers and acquisitions, but then, that would make life simple……Read more
 
HCC Best Practices for Proactive Medical Management
March 18-19, 2013 – Sheraton Music City Hotel – Nashville, TN
We are pleased to announce our 4th Annual HCC Best Practices conference. This conference will build on the success of the 2011 and 2012 conferences while providing practical, timely updates to help you continue to evolve your medical management practices with sound HCC coding.
www.opalevents.org/trk/hccb1301.html
 
Spotlight on: Pharmaceuticals
Close but no cigar for Allergan, Inc. (NYSE: AGN), considering it missed the billion-dollar mark with its $958 million acquisition for MAP Pharmaceuticals, Inc. (NASDAQ: MAPP). Or perhaps the global health care giant deserves a cigar after all, for buying the biopharmaceutical company…….Read more
 
Conference Calendar…Click here to see more